Your browser doesn't support javascript.
loading
Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts.
Campos, Adrian I; Thompson, Paul M; Veltman, Dick J; Pozzi, Elena; van Veltzen, Laura S; Jahanshad, Neda; Adams, Mark J; Baune, Bernhard T; Berger, Klaus; Brosch, Katharina; Bülow, Robin; Connolly, Colm G; Dannlowski, Udo; Davey, Christopher G; de Zubicaray, Greig I; Dima, Danai; Erwin-Grabner, Tracy; Evans, Jennifer W; Fu, Cynthia H Y; Gotlib, Ian H; Goya-Maldonado, Roberto; Grabe, Hans J; Grotegerd, Dominik; Harris, Matthew A; Harrison, Ben J; Hatton, Sean N; Hermesdorf, Marco; Hickie, Ian B; Ho, Tiffany C; Kircher, Tilo; Krug, Axel; Lagopoulos, Jim; Lemke, Hannah; McMahon, Katie; MacMaster, Frank P; Martin, Nicholas G; McIntosh, Andrew M; Medland, Sarah E; Meinert, Susanne; Meller, Tina; Nenadic, Igor; Opel, Nils; Redlich, Ronny; Reneman, Liesbeth; Repple, Jonathan; Sacchet, Matthew D; Schmitt, Simon; Schrantee, Anouk; Sim, Kang; Singh, Aditya.
Afiliação
  • Campos AI; Genetic Epidemiology Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Thompson PM; Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, California.
  • Veltman DJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Pozzi E; Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • van Veltzen LS; Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • Jahanshad N; Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, California.
  • Adams MJ; Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
  • Baune BT; Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Berger K; Institute of Epidemiology and Social Medicine, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Brosch K; Department of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
  • Bülow R; Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany.
  • Connolly CG; Department of Biomedical Sciences, Florida State University, Tallahassee, Florida.
  • Dannlowski U; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Davey CG; Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
  • de Zubicaray GI; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Dima D; Department of Psychology, School of Arts and Social Sciences, City, University of London, London, United Kingdom; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Erwin-Grabner T; Laboratory of Systems Neuroscience and Imaging in Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Lower Saxony, Germany.
  • Evans JW; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
  • Fu CHY; Centre for Affective Disorders, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom; School of Psychology, University of East London, London, United Kingdom.
  • Gotlib IH; Department of Psychology, Stanford University, Stanford, California.
  • Goya-Maldonado R; Laboratory of Systems Neuroscience and Imaging in Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Lower Saxony, Germany.
  • Grabe HJ; German Center for Neurodegenerative Disease, Greifswald, Mecklenburg-Vorpommern, Germany.
  • Grotegerd D; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Harris MA; Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
  • Harrison BJ; Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
  • Hatton SN; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Hermesdorf M; Institute of Epidemiology and Social Medicine, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Hickie IB; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Ho TC; Department of Psychiatry & Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California.
  • Kircher T; Department of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
  • Krug A; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, North Rhine-Westphalia, Germany; Department of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
  • Lagopoulos J; Thompson Institute, University of the Sunshine Coast, Sunshine Coast, Queensland, Australia; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Lemke H; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • McMahon K; Herston Imaging Research Facility & School of Clinical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
  • MacMaster FP; Department of Pediatrics and Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Strategic Clinical Network for Addictions and Mental Health, Alberta Health Services, Calgary, Alberta, Canada.
  • Martin NG; Genetic Epidemiology Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • McIntosh AM; Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
  • Medland SE; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Psychiatric Genetics Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Austalia; School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
  • Meinert S; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Meller T; Department of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
  • Nenadic I; Department of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
  • Opel N; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Redlich R; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Reneman L; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands.
  • Repple J; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
  • Sacchet MD; Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, Massachusetts.
  • Schmitt S; Department of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
  • Schrantee A; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands.
  • Sim K; West Region, Institute of Mental Health, Buangkok View, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Singh A; Laboratory of Systems Neuroscience and Imaging in Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Lower Saxony, Germany.
Biol Psychiatry ; 90(4): 243-252, 2021 08 15.
Article em En | MEDLINE | ID: mdl-34172278
ABSTRACT

BACKGROUND:

Neuroimaging studies of suicidal behavior have so far been conducted in small samples, prone to biases and false-positive associations, yielding inconsistent results. The ENIGMA-MDD Working Group aims to address the issues of poor replicability and comparability by coordinating harmonized analyses across neuroimaging studies of major depressive disorder and related phenotypes, including suicidal behavior.

METHODS:

Here, we pooled data from 18 international cohorts with neuroimaging and clinical measurements in 18,925 participants (12,477 healthy control subjects and 6448 people with depression, of whom 694 had attempted suicide). We compared regional cortical thickness and surface area and measures of subcortical, lateral ventricular, and intracranial volumes between suicide attempters, clinical control subjects (nonattempters with depression), and healthy control subjects.

RESULTS:

We identified 25 regions of interest with statistically significant (false discovery rate < .05) differences between groups. Post hoc examinations identified neuroimaging markers associated with suicide attempt including smaller volumes of the left and right thalamus and the right pallidum and lower surface area of the left inferior parietal lobe.

CONCLUSIONS:

This study addresses the lack of replicability and consistency in several previously published neuroimaging studies of suicide attempt and further demonstrates the need for well-powered samples and collaborative efforts. Our results highlight the potential involvement of the thalamus, a structure viewed historically as a passive gateway in the brain, and the pallidum, a region linked to reward response and positive affect. Future functional and connectivity studies of suicidal behaviors may focus on understanding how these regions relate to the neurobiological mechanisms of suicide attempt risk.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tentativa de Suicídio / Transtorno Depressivo Maior Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biol Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tentativa de Suicídio / Transtorno Depressivo Maior Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biol Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália